Stem Cell Authority, Ltd.

OTC: SCAL · Healthcare · Medical - Care Facilities

PublicHQ Fairlawn, OH · SummitReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 47

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ balance-sheet leverage, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$4.2k

Employees

—

Market cap

$17.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02023

Net income-$4.2k-$4.2k2023

Operating income-$4.2k-$4.2k2023

Total assets$15$152002

Liabilities$80.5k$80.5k2002

Equity-$80.5k-$80.5k2002

Revenue trend

FY2001 – FY2023 · USD

FY01

FY02

FY23

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Stem Cell Authority, Ltd. booked $0 in FY2023 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Itoco Inc.——ARYx Therapeutics, Inc.——Lattice Biologics Ltd.——Wuhan General Group (China), Inc.——

Neighbors

Summit →

FirstEnergy Corp.$15.1B68B Diebold Nixdorf, Incorporated$3.8B70B The Goodyear Tire & Rubber Company$18.3B46D Babcock & Wilcox Enterprises, Inc.$587.7M45D Arhaus, Inc.$1.4B51D Myers Industries, Inc.$825.7M64C

Key facts

CEOCarlzo Bernard Cardwell

SectorHealthcare

IndustryMedical - Care Facilities

HeadquartersFairlawn, OH

ExchangeOTC: SCAL

Employees—

IPO date2005-03-17

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.